| Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
| Erin Ellingto. Clozapine Use in Early-Onset Schizophrenia. Journal of psychosocial nursing and mental health services. vol 61. issue 2. 2023-01-31. PMID:36720054. |
clozapine use in early-onset schizophrenia. |
2023-01-31 |
2023-08-14 |
Not clear |
| Lydia Hahl-Häkkinen, Susanna Maria Rask, Anssi Solismaa, Sanna Ruuhonen, Esa Leinone. Co-medication with disulfiram markedly increased serum clozapine levels: Two case reports. Journal of psychopharmacology (Oxford, England). 2023-01-27. PMID:36703576. |
clozapine offers some benefits in treating patients with refractory schizophrenia and aud, but co-medicating with disulfiram is also common. |
2023-01-27 |
2023-08-14 |
Not clear |
| Nobuhisa Kanahara, Hiroshi Kimura, Toshihiko Kinoshita, Masaomi Iyo, Yoshiteru Takekit. Efficacy of Asenapine in Drug-resistant Psychotic Patients with Dopamine Supersensitivity Psychosis: Two Cases. Clinical psychopharmacology and neuroscience : the official scientific journal of the Korean College of Neuropsychopharmacology. vol 21. issue 1. 2023-01-26. PMID:36700326. |
an antipsychotic agent with both tight binding to drd2 and a long half-life is generally effective for treating dsp, but a patient who meets the criteria of treatment-resistant schizophrenia sometimes needs treatment with clozapine. |
2023-01-26 |
2023-08-14 |
Not clear |
| Nina Treder, Albert Martínez-Pinteño, Natalia Rodríguez, Néstor Arbelo, Santiago Madero, Marta Gómez, Clemente García-Rizo, Sergi Mas, Patricia Gassó, Eduard Parellada, Constanza Moré. The Effect of Clozapine and Novel Glutamate Modulator JNJ-46356479 on Nitrosative Stress in a Postnatal Murine Ketamine Model of Schizophrenia. International journal of molecular sciences. vol 24. issue 2. 2023-01-21. PMID:36674542. |
the effect of clozapine and novel glutamate modulator jnj-46356479 on nitrosative stress in a postnatal murine ketamine model of schizophrenia. |
2023-01-21 |
2023-08-14 |
Not clear |
| Brian J Miller, Joseph P McEvoy, William V McCal. Meta-analysis of clozapine and insomnia in schizophrenia. Schizophrenia research. vol 252. 2023-01-20. PMID:36669344. |
meta-analysis of clozapine and insomnia in schizophrenia. |
2023-01-20 |
2023-08-14 |
Not clear |
| Brian J Miller, Joseph P McEvoy, William V McCal. Meta-analysis of clozapine and insomnia in schizophrenia. Schizophrenia research. vol 252. 2023-01-20. PMID:36669344. |
we performed a meta-analysis of insomnia in randomized controlled trials (rcts) of patients with schizophrenia treated with clozapine. |
2023-01-20 |
2023-08-14 |
Not clear |
| Michelle I Jakobsen, Julie P Schaug, Jimmi Nielsen, Erik Simonse. Antipsychotic prescribing practices for outpatients with schizophrenia and reasons for non-clozapine treatment - Data from a Danish quality assessment audit. Nordic journal of psychiatry. 2023-01-18. PMID:36651766. |
clozapine is the gold standard for treating treatment-resistant schizophrenia (trs) although widely underutilised. |
2023-01-18 |
2023-08-14 |
Not clear |
| Ranel Troy Santos, Sandra Mullen, Ericka L Crouse, Katie S Adam. Comparison of clozapine doses and tolerability in patients with and without concurrent valproic acid. The mental health clinician. vol 12. issue 6. 2023-01-16. PMID:36644583. |
valproic acid (vpa) and its various formulations can be given in conjunction with clozapine for seizure prophylaxis or for augmentation in schizophrenia. |
2023-01-16 |
2023-08-14 |
Not clear |
| Vasilios G Masdrakis, David S Baldwi. Prevention of suicide by clozapine in mental disorders: systematic review. European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology. vol 69. 2023-01-14. PMID:36640481. |
previous research has investigated the efficacy of clozapine in reducing suicidality in patients with schizophrenia and schizoaffective disorder. |
2023-01-14 |
2023-08-14 |
Not clear |
| Yuhei Amano, Jun Mazda, Koichi Amano, Kazutaka Ohi, Toshiki Shioir. Efficacy of sofpironium bromide gel on clozapine-induced hypersalivation in patients with treatment-resistant schizophrenia: double-blind, controlled crossover study. BJPsych open. vol 9. issue 1. 2023-01-13. PMID:36636808. |
hypersalivation is a major side-effect of clozapine in patients with treatment-resistant schizophrenia. |
2023-01-13 |
2023-08-14 |
Not clear |
| Fei Wang, Zhuo-Hui Huang, Christine Migliorini, Shi-Bin Wang, Zi-Lang Chen, Qian-Wen Wang, Xiao-Yan He, Carol Harvey, Cai-Lan Ho. Two-year cohort-up study of clozapine prescription in Chinese patients with schizophrenia treated in rural primary care. Asian journal of psychiatry. vol 81. 2023-01-05. PMID:36603401. |
two-year cohort-up study of clozapine prescription in chinese patients with schizophrenia treated in rural primary care. |
2023-01-05 |
2023-08-14 |
human |
| Fei Wang, Zhuo-Hui Huang, Christine Migliorini, Shi-Bin Wang, Zi-Lang Chen, Qian-Wen Wang, Xiao-Yan He, Carol Harvey, Cai-Lan Ho. Two-year cohort-up study of clozapine prescription in Chinese patients with schizophrenia treated in rural primary care. Asian journal of psychiatry. vol 81. 2023-01-05. PMID:36603401. |
few studies have examined the clozapine in cohort studies of chinese patients with schizophrenia in rural primary care. |
2023-01-05 |
2023-08-14 |
human |
| Fei Wang, Zhuo-Hui Huang, Christine Migliorini, Shi-Bin Wang, Zi-Lang Chen, Qian-Wen Wang, Xiao-Yan He, Carol Harvey, Cai-Lan Ho. Two-year cohort-up study of clozapine prescription in Chinese patients with schizophrenia treated in rural primary care. Asian journal of psychiatry. vol 81. 2023-01-05. PMID:36603401. |
the objective of this two-year cohort study was to describe the usage of clozapine and investigate and identify the demographic, clinical correlations and risk variables which affect the use of clozapine in patients with schizophrenia. |
2023-01-05 |
2023-08-14 |
human |
| Fei Wang, Zhuo-Hui Huang, Christine Migliorini, Shi-Bin Wang, Zi-Lang Chen, Qian-Wen Wang, Xiao-Yan He, Carol Harvey, Cai-Lan Ho. Two-year cohort-up study of clozapine prescription in Chinese patients with schizophrenia treated in rural primary care. Asian journal of psychiatry. vol 81. 2023-01-05. PMID:36603401. |
the variables for clozapine use in individuals with schizophrenia who had undergone a two-year follow-up were determined using the generalized estimating equation (gee). |
2023-01-05 |
2023-08-14 |
human |
| Fei Wang, Zhuo-Hui Huang, Christine Migliorini, Shi-Bin Wang, Zi-Lang Chen, Qian-Wen Wang, Xiao-Yan He, Carol Harvey, Cai-Lan Ho. Two-year cohort-up study of clozapine prescription in Chinese patients with schizophrenia treated in rural primary care. Asian journal of psychiatry. vol 81. 2023-01-05. PMID:36603401. |
the usage of clozapine was very common in patients with schizophrenia treated by primary care physicians, and was influenced by a variety of factors, including price of drugs, clinical factors, health regulations, and the characteristics of treatment environment. |
2023-01-05 |
2023-08-14 |
human |
| Mustafa Tuncturk, Cagatay Ermis, Dicle Buyuktaskin, Serkan Turan, Yesim Saglam, Sezen Alarslan, Duru Guler, Ekin Sut, Guldal Unutmaz, Ayse Beste Guzel, Ozge Atay Canbek, Neslihan Inal, Gul Karacetin, Philip Hazel. Electroconvulsive therapy or clozapine for adolescents with treatment-resistant schizophrenia: an explorative analysis on symptom dimensions. International journal of psychiatry in clinical practice. 2022-12-28. PMID:36576216. |
electroconvulsive therapy or clozapine for adolescents with treatment-resistant schizophrenia: an explorative analysis on symptom dimensions. |
2022-12-28 |
2023-08-14 |
Not clear |
| Vaios Peritogiannis, Angeliki Ninou, Maria Samakour. Mortality in Schizophrenia-Spectrum Disorders: Recent Advances in Understanding and Management. Healthcare (Basel, Switzerland). vol 10. issue 12. 2022-12-23. PMID:36553890. |
long-term antipsychotic use (including clozapine and long-acting injectables) is associated with substantially decreased all-cause mortality, including suicide and cardiovascular mortality, in patients with schizophrenia despite the well-known cardiometabolic adverse effects of second-generation agents. |
2022-12-23 |
2023-08-14 |
Not clear |
| Bochao D Lin, Justo Pinzón-Espinosa, Elodie Blouzard, Marte Z van der Horst, Cynthia Okhuijsen-Pfeifer, Kristel R van Eijk, Sinan Guloksuz, Wouter J Peyrot, Jurjen J Luyk. Associations Between Polygenic Risk Score Loading, Psychosis Liability, and Clozapine Use Among Individuals With Schizophrenia. JAMA psychiatry. 2022-12-21. PMID:36542388. |
associations between polygenic risk score loading, psychosis liability, and clozapine use among individuals with schizophrenia. |
2022-12-21 |
2023-08-14 |
Not clear |
| Bochao D Lin, Justo Pinzón-Espinosa, Elodie Blouzard, Marte Z van der Horst, Cynthia Okhuijsen-Pfeifer, Kristel R van Eijk, Sinan Guloksuz, Wouter J Peyrot, Jurjen J Luyk. Associations Between Polygenic Risk Score Loading, Psychosis Liability, and Clozapine Use Among Individuals With Schizophrenia. JAMA psychiatry. 2022-12-21. PMID:36542388. |
predictors consistently associated with psychosis liability and course of illness in schizophrenia (scz) spectrum disorders (ssd), including the need for clozapine treatment, are lacking. |
2022-12-21 |
2023-08-14 |
Not clear |
| D Sanagustin, M Martin-Subero, B Hogg, L Fortea, I Gardoki, D Guinart, M Roldán, M Angelats, L Cerro, D Navas, J D Jiménez, L Ortiz, R Ros, X Polo, Y Ventura, J Contreras, A Moreno-Alcázar, V Pérez-Sola, B L Amann, A Valiente-Góme. Prevalence of clozapine-induced sialorrhea and its effect on quality of life. Psychopharmacology. 2022-12-20. PMID:36538098. |
clozapine has proven to be superior to other antipsychotic drugs in the treatment of schizophrenia but is under-prescribed due to its potentially severe side effects. |
2022-12-20 |
2023-08-14 |
Not clear |